145 related articles for article (PubMed ID: 19025608)
21. Global protein-expression profiling for reclassification of malignant fibrous histiocytoma.
Kikuta K; Morioka H; Kawai A; Kondo T
Biochim Biophys Acta; 2015 Jun; 1854(6):696-701. PubMed ID: 25173742
[TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of promyelocytic leukemia expression in gastrointestinal stromal tumor; integrated proteomic and transcriptomic analysis.
Ichikawa H; Yoshida A; Kanda T; Kosugi S; Ishikawa T; Hanyu T; Taguchi T; Sakumoto M; Katai H; Kawai A; Wakai T; Kondo T
Cancer Sci; 2015 Jan; 106(1):115-24. PubMed ID: 25457157
[TBL] [Abstract][Full Text] [Related]
23. Molecular and immunohistochemical p53 status in liposarcoma and malignant fibrous histiocytoma: identification of seven new mutations for soft tissue sarcomas.
Taubert H; Würl P; Meye A; Berger D; Thamm B; Neumann K; Hinze R; Schmidt H; Rath FW
Cancer; 1995 Oct; 76(7):1187-96. PubMed ID: 8630896
[TBL] [Abstract][Full Text] [Related]
24. The arsenic-based cure of acute promyelocytic leukemia promotes cytoplasmic sequestration of PML and PML/RARA through inhibition of PML body recycling.
Lång E; Grudic A; Pankiv S; Bruserud O; Simonsen A; Bjerkvig R; Bjørås M; Bøe SO
Blood; 2012 Jul; 120(4):847-57. PubMed ID: 22692509
[TBL] [Abstract][Full Text] [Related]
25. PML and TRF2 protein expression in hereditary and sporadic colon cancer.
Plevová P; Bouchal J; Fiurásková M; Papezová M; Krepelová A; Curík R; Foretová L; Navrátilová M; Zapletalová J; Posolda T; Kolár Z
Neoplasma; 2007; 54(4):269-77. PubMed ID: 17822315
[TBL] [Abstract][Full Text] [Related]
26. Moloney murine leukemia virus integrase and reverse transcriptase interact with PML proteins.
Okino Y; Inayoshi Y; Kojima Y; Kidani S; Kaneoka H; Honkawa A; Higuchi H; Nishijima K; Miyake K; Iijima S
J Biochem; 2012 Aug; 152(2):161-9. PubMed ID: 22685230
[TBL] [Abstract][Full Text] [Related]
27. Viral disruption of promyelocytic leukemia (PML) nuclear bodies by hijacking host PML regulators.
Frappier L
Virulence; 2011; 2(1):58-62. PubMed ID: 21217204
[TBL] [Abstract][Full Text] [Related]
28. PML-nuclear bodies accumulate DNA in response to polyomavirus BK and simian virus 40 replication.
Jul-Larsen A; Visted T; Karlsen BO; Rinaldo CH; Bjerkvig R; Lønning PE; Bøe SO
Exp Cell Res; 2004 Aug; 298(1):58-73. PubMed ID: 15242762
[TBL] [Abstract][Full Text] [Related]
29. Promyelocytic leukemia nuclear bodies provide a scaffold for human polyomavirus JC replication and are disrupted after development of viral inclusions in progressive multifocal leukoencephalopathy.
Shishido-Hara Y; Higuchi K; Ohara S; Duyckaerts C; Hauw JJ; Uchihara T
J Neuropathol Exp Neurol; 2008 Apr; 67(4):299-308. PubMed ID: 18379438
[TBL] [Abstract][Full Text] [Related]
30. Cross talk between PML and p53 during poliovirus infection: implications for antiviral defense.
Pampin M; Simonin Y; Blondel B; Percherancier Y; Chelbi-Alix MK
J Virol; 2006 Sep; 80(17):8582-92. PubMed ID: 16912307
[TBL] [Abstract][Full Text] [Related]
31. The promyelocytic leukemia nuclear body: sites of activity?
Eskiw CH; Bazett-Jones DP
Biochem Cell Biol; 2002; 80(3):301-10. PubMed ID: 12123283
[TBL] [Abstract][Full Text] [Related]
32. Apoptin is modified by SUMO conjugation and targeted to promyelocytic leukemia protein nuclear bodies.
Janssen K; Hofmann TG; Jans DA; Hay RT; Schulze-Osthoff K; Fischer U
Oncogene; 2007 Mar; 26(11):1557-66. PubMed ID: 16924230
[TBL] [Abstract][Full Text] [Related]
33. Pondering the puzzle of PML (promyelocytic leukemia) nuclear bodies: can we fit the pieces together using an RNA regulon?
Borden KL
Biochim Biophys Acta; 2008 Nov; 1783(11):2145-54. PubMed ID: 18616965
[TBL] [Abstract][Full Text] [Related]
34. Heterogeneous nuclear expression of the promyelocytic leukemia (PML) protein in normal and neoplastic human tissues.
Gambacorta M; Flenghi L; Fagioli M; Pileri S; Leoncini L; Bigerna B; Pacini R; Tanci LN; Pasqualucci L; Ascani S; Mencarelli A; Liso A; Pelicci PG; Falini B
Am J Pathol; 1996 Dec; 149(6):2023-35. PubMed ID: 8952536
[TBL] [Abstract][Full Text] [Related]
35. AXIN is an essential co-activator for the promyelocytic leukemia protein in p53 activation.
Li Q; He Y; Wei L; Wu X; Wu D; Lin S; Wang Z; Ye Z; Lin SC
Oncogene; 2011 Mar; 30(10):1194-204. PubMed ID: 21057547
[TBL] [Abstract][Full Text] [Related]
36. Dysregulation of promyelocytic leukemia (PML) protein expression in preeclamptic placentae.
Leavenworth JD; Groesch KA; Xin Hu ; Malm S; Torry RJ; Abrams R; Torry DS
Reprod Sci; 2010 Apr; 17(4):339-49. PubMed ID: 20228380
[TBL] [Abstract][Full Text] [Related]
37. TTRAP is a novel PML nuclear bodies-associated protein.
Xu GL; Pan YK; Wang BY; Huang L; Tian L; Xue JL; Chen JZ; Jia W
Biochem Biophys Res Commun; 2008 Oct; 375(3):395-8. PubMed ID: 18706885
[TBL] [Abstract][Full Text] [Related]
38. The expression of c-Met pathway components in unclassified pleomorphic sarcoma/malignant fibrous histiocytoma (UPS/MFH): a tissue microarray study.
Lahat G; Zhang P; Zhu QS; Torres K; Ghadimi M; Smith KD; Wang WL; Lazar AJ; Lev D
Histopathology; 2011 Sep; 59(3):556-61. PubMed ID: 22034893
[TBL] [Abstract][Full Text] [Related]
39. c-Myb associates with PML in nuclear bodies in hematopoietic cells.
Dahle Ø; Bakke O; Gabrielsen OS
Exp Cell Res; 2004 Jul; 297(1):118-26. PubMed ID: 15194430
[TBL] [Abstract][Full Text] [Related]
40. Inflammatory malignant fibrous histiocytomas and dedifferentiated liposarcomas: histological review, genomic profile, and MDM2 and CDK4 status favour a single entity.
Coindre JM; Hostein I; Maire G; Derré J; Guillou L; Leroux A; Ghnassia JP; Collin F; Pedeutour F; Aurias A
J Pathol; 2004 Jul; 203(3):822-30. PubMed ID: 15221942
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
